omniture
药明生物 WuXi Biologics

Latest News

WuXi Biologics Launched Biologics Integrated Innovation Center in Hangzhou

HANGZHOU, China, Nov. 20, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global comp...

2020-11-20 16:30 439

WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa

* Tadekinig alfa is a novel IL-18 binding protein in pivotal Phase 3 testing for orphan disease I...

2020-10-29 17:00 518

WuXi Biologics Records Excellent Interim Results

Revenue Up 21.0% Y-o-Y to RMB1,944.1 Million Net Profit Up 62.6% to RMB730.7 Million Profit Attribut...

2020-08-18 00:51 1493

WuXi Vaccines Appoints Mr. Jian Dong as Chief Executive Officer

SHANGHAI and DUNDALK, Ireland, Aug. 6, 2020 /PRNewswire/ -- WuXi Vaccines, a global leading company...

2020-08-06 17:00 1266

WuXi Biologics Awarded as "Most Honored Company" by Institutional Investor

SHANGHAI, Aug. 4, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with...

2020-08-04 17:00 1051

Embrace Change to Turn Challenges into Opportunities: WuXi Biologics Successfully Hosted the 2nd Investor Day

SHANGHAI, June 19, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company wit...

2020-06-19 17:56 709

WuXi Biologics (Suzhou) Received EMA GMP Certificate for Biosafety Testing

* One of few third-party biosafety testing providers certified by EMA GMP standards inChina even ...

2020-06-16 08:00 815

WuXi Biologics Signs Lease for a Clinical Manufacturing Facility in the United States

CRANBURY, NJ and SHANGHAI, June 9, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a gl...

2020-06-09 08:00 532

WuXi Biologics Sweeps 2020 CMO Leadership Awards in All Six Categories

SHANGHAI and NEW YORK, May 28, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global...

2020-05-28 08:00 847

WuXi Biologics Closes Land Deal to Build State-of-the-Art Biologics Production Facility in the United States

SHANGHAI and WORCESTER, Mass., May 19, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), ...

2020-05-19 08:00 1003

WuXi Biologics and Aravive Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies Targeting Cancer and Fibrosis Using the WuXiBody™ Platform

SHANGHAI and HOUSTON, April 30, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a glob...

2020-04-30 19:00 343

WuXi Biologics Successfully Completes PFS Filling at its Robotic Aseptic Filling Facility

* First GMP facility in WuXi Biologics to use robotic aseptic filling line for biologics * Demo...

2020-04-28 08:00 736

WuXi Biologics Completed Acquisition of a Drug Product Manufacturing Facility in Germany

SHANGHAI and LEVERKUSEN, Germany, April 22, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269....

2020-04-22 08:00 695

WuXi Biologics (Suzhou) Successfully Passed First EMA GMP Inspection

SUZHOU, China, April 13, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global compa...

2020-04-14 08:00 5690

WuXi Biologics Achieved Remarkable Results in 2019

57.2% Revenue Growth to RMB3,983.7 Million 63.0% Gross Profit Growth to RMB1,658.8 Million Adjuste...

2020-03-26 21:32 4874

WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland

DUNDALK, Ireland, March 11, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading g...

2020-03-11 08:00 652

WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19

SAN FRANCISCO and SHANGHAI, Feb. 25, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a ...

2020-02-25 21:30 787

WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321

SHANGHAI, Feb. 23, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global ope...

2020-02-24 08:00 4414

WuXi Biologics' Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader

SHANGHAI, Feb. 18, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global op...

2020-02-18 18:42 655

WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader

SHANGHAI, Feb. 18, 2020 /PRNewswire/ -- WuXi Vaccines, a new vaccine Contract Development and Manuf...

2020-02-18 18:18 893
12345